Cansino Biologics, Inc. Class ASSE: 688185

Announcement on Obtaining the Drug Registration Certificate for the Adsorbed Inactivated (Three-component) Diphtheria-Tetanus-Pertussis Vaccine for Infants and Young Children

· Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange
Announcement on Obtaining the Drug Registration Certificate for the Adsorbed Inactivated (Three-component) Diphtheria-Tetanus-Pertussis Vaccine for Infants and Young Children

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis